3-(4-chlorophenyl)-adamantane-1-carboxylic acid (pyridin-4-ylmethyl)amide

sphingosine kinase 2 ; Mus musculus







7 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 33171607 A Novel Selective Sphingosine Kinase 2 Inhibitor, HWG-35D, Ameliorates the Severity of Imiquimod-Induced Psoriasis Model by Blocking Th17 Differentiation of Naïve CD4 T Lymphocytes. 2020 Nov 8 1
2 28175299 Inhibiting sphingosine kinase 2 mitigates mutant Huntingtin-induced neurodegeneration in neuron models of Huntington disease. 2017 Apr 1 1
3 26719367 Elevated Nuclear and Cytoplasmic FTY720-Phosphate in Mouse Embryonic Fibroblasts Suggests the Potential for Multiple Mechanisms in FTY720-Induced Neural Tube Defects. 2016 Mar 1
4 26905748 Elevated nuclear sphingoid base-1-phosphates and decreased histone deacetylase activity after fumonisin B1 treatment in mouse embryonic fibroblasts. 2016 May 1 1
5 26494858 The Sphingosine Kinase 2 Inhibitor ABC294640 Reduces the Growth of Prostate Cancer Cells and Results in Accumulation of Dihydroceramides In Vitro and In Vivo. 2015 Dec 1
6 21756852 Sphingosine kinase-2 inhibition improves mitochondrial function and survival after hepatic ischemia-reperfusion. 2012 Jan 1
7 21258214 Antitumor activity of sphingosine kinase 2 inhibitor ABC294640 and sorafenib in hepatocellular carcinoma xenografts. 2011 Mar 1 2